This Issue
- China: Gaining Entry
- Spotlight
-
Pharmaceutical companies in a fierce race to bring their products to market have begun to regard economically burgeoning China as an R&D paradise.
- A World Away
- development
-
Finding solutions for the neglected tropical diseases that affect one billion people worldwide requires not only a commitment to conduct sorely needed research, but also a rethinking of drug development’s value proposition.
- Biotechs and the Public Market
- development
-
After a disastrous first half of 2008, the question becomes: Are IPOs still fueling the biotech industry?
- Outside Perspective
- management
-
As the biopharmaceutical industry undergoes massive, transformational change, many companies are looking outside the industry to fill leadership positions.
- Europe: The Hard Cell
- development
-
Stem cell research receives official funding from the European Parliament. But the opportunities this presents for EU researchers remain complex and controversial.
- Simulating Science
- management
-
Through clinical trial simulation, researchers can generate a fuller understanding of their drug and its potential effects, leading to better designed—and possibly less expensive—trials.
- The Meaning of Meta-Analyses
- commercialization
-
Meta-analyses can play a role in advancing scientific knowledge
for any given drug. But if poorly designed or hastily conducted, they can be damaging for an approved medicine.
MediaCast
- Uncharted Waters
- Mediacast
-
Sandy Hillsberg, managing partner with Los Angeles-based law firm TroyGould, discusses how the global financial crisis is affecting emerging biotechnology companies.
Web Exclusives
- Statistical Advantage
-
Gary Shorter, director of biostatistics for Quintiles, talks to Envisage editor Adam Istas about the growing importance of incorporating biostatistical analysis into all stages of drug development.
- Measure for Measure
-
A proposed Health Care Comparative Effectiveness Research Institute in the United States may force the biopharmaceutical industry to emphasize patient outcomes and quality of life issues when developing a new medicinal product.
Columns
- Specialty Sales in the Global Marketplace
-
James Lennertz, head of global operations at Innovex, discusses the changing role of specialty sales reps.
- Safety through Standards
-
Paula Brown Stafford, executive vice president of global data management at Quintiles, discusses how universal data standards can help ensure better patient safety across all phases of clinical research.
Most Read
